000026599 000__ 04448cam\a2200733\i\4500
000026599 001__ 26599
000026599 003__ SzGeWIPO
000026599 005__ 20230203210714.0
000026599 008__ 110428s2011\\\\enka\\\\rb\\\\001\0\eng\\
000026599 020__ $$z9780857938794$$qPrint
000026599 020__ $$z9780857938619$$qeBook
000026599 035__ $$a(wipo)006646201
000026599 035__ $$a(OCoLC)751739300
000026599 040__ $$aStDuBDS$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000026599 041__ $$aeng
000026599 043__ $$ad------
000026599 050_4 $$aK3636$$b.I577 2011
000026599 050_4 $$aHD9674.D44$$bI58 2011eb
000026599 08204 $$a346.1240486$$222
000026599 084__ $$aG 25 SHA.I
000026599 090__ $$c28995$$d28985
000026599 1001_ $$aShadlen, Kenneth C.,$$aGuennif, Samira.,$$aGuzmán, Alenka.,$$aLalitha, Narayanan.$$eEditors.
000026599 24510 $$aIntellectual Property, Pharmaceuticals and Public Health  :$$bAccess to Drugs in Developing Countries.
000026599 264_1 $$aCheltenham, UK :$$bEdward Elgar,$$c2011.
000026599 300__ $$a352 pages :$$billustrations ;$$c24 cm
000026599 336__ $$atext$$btxt$$2rdacontent
000026599 337__ $$aunmediated$$bn$$2rdamedia
000026599 338__ $$avolume$$bnc$$2rdacarrier
000026599 504__ $$aIncludes bibliographical references and index.
000026599 5050_ $$a1. Globalization, Intellectual Property Rights, and Pharmaceuticals: Meeting the Challenges to Addressing Health Gaps in the New International Environment -- 2. Pharmaceutical Production and Access to Essential Medicines in South Africa -- 3. Intellectual Property and Access to Medicines: Paradoxes in Moroccan Policy -- 4. The Invisible Threat: Trade, Intellectual Property, and Pharmaceutical Regulations in Colombia -- 5. The Challenges of Constructing Pharmaceutical Capabilities and Promoting Access to Medicines in Mexico under TRIPS -- 6. Corporate Power and State Resistance: Brazil’s Use of TRIPS Flexibilities for its National AIDS Program -- 7. The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies -- 8. Pharmaceutical Patent Policy in Developing Countries: Learning from the Canadian Experience -- 9. Access to Indian Generic Drugs: Emerging Issues -- 10. Sufficient but Expensive Drugs: A Double-Track System that Facilitated Supply Capability in China -- 11. Access to Essential Drugs in Thailand: Intellectual Property Rights and Other Institutional Matters Affecting Public Health in a Developing Country -- 12. The TRIPS Agreement and Health Innovation in Bangladesh -- Index
000026599 520__ $$aThis up-to-date book examines pharmaceutical development, access to medicines, and the protection of public health in the context of two fundamental changes that the global political economy has undergone since the 1970s, the globalization of trade and production and the increased harmonization of national regulations on intellectual property rights.  With authors from eleven different countries presenting case studies of national experiences in Africa, Asia and the Americas, the book analyzes national strategies to promote pharmaceutical innovation, while at the same time assuring widespread access to medicines through generic pharmaceutical production and generic pharmaceutical importation. The expert chapters focus on patents as well as an array of regulatory instruments, including pricing and drug registration policies.  Presenting in-depth analysis and original empirical research, this book will strongly appeal to academics and students of intellectual property, international health, international political economy, international development and law.
000026599 63000 $$aAgreement on Trade-Related Aspects of Intellectual Property Rights$$d(1994 April 15)
000026599 650_0 $$aPharmaceutical policy$$zDeveloping countries.
000026599 650_0 $$aPharmaceutical industry$$zDeveloping countries.
000026599 650_0 $$aPharmaceutical services$$zDeveloping countries.
000026599 650_0 $$aPublic health$$zDeveloping countries.
000026599 650_0 $$aPatents$$zDeveloping countries.
000026599 650_0 $$aDrug accessibility$$xLaw and legislation$$zDeveloping countries.
000026599 650_0 $$aIntellectual property$$zDeveloping countries.
000026599 650_4 $$aDrugs
000026599 650_6 $$aSanté publique$$xDroit international.
000026599 650_6 $$aDroit à la santé$$zPays en voie de développement.
000026599 650_6 $$aMédicaments$$xBrevets d'invention.
000026599 651_0 $$aDeveloping countries$$xCommerce$$xLaw and legislation.
000026599 653__ $$aDeveloping countries
000026599 7001_ $$aT. Andia,$$aM. Bourassa Forcier,$$aM. Flynn,$$aP. Gehl Sampath,$$aS. Guennif,$$aA. Guzmán,$$aH. Klug,$$aG. Krikorian,$$aN. Lalitha,$$aJ.-F. Morin,$$aK.C. Shadlen,$$aL. Shi, M. Watanabe$$eContributors.
000026599 85640 $$uhttps://www.elgaronline.com/display/9781849800143.xml$$yView eBook
000026599 942__ $$cMON$$jG 25 SHA.I
000026599 952__ $$w2011-12-08$$p2011-0601$$r0.00$$u41047$$bMAIN$$10$$kG 25 SHA.I$$v2011-12-08$$zTagged$$71
000026599 952__ $$w2011-12-08$$p2011-0602$$r0.00$$u41049$$bMAIN$$10$$kG 25 SHA.I$$v2011-12-08$$zTagged$$71
000026599 980__ $$aBIB$$aOS
000026599 999__ $$c28995$$d28995